Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryosuke Suzuki

Showing results (171-180 of 192) with videos related to

Pageof 20
Sort By:
The Journal of Biological Chemistry|December 15, 2019
The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal networkMasashi Iwamoto, Wakana Saso, Kazane Nishioka, et al.
World Journal of Urology|June 2, 2026
Applying classification of intraoperative adverse events (ClassIntra) to robot-assisted radical prostatectomy to predict the risk of postoperative adverse eventsShinya Somiya, Ryoichi Saito, Toru Kanno, et al.
Nature Communications|May 5, 2016
TRC8-dependent degradation of hepatitis C virus immature core protein regulates viral propagation and pathogenesisSayaka Aizawa, Toru Okamoto, Yukari Sugiyama, et al.
Vaccine|September 5, 2022
Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathologyTakuya Hemmi, Akira Ainai, Takao Hashiguchi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|June 28, 2019
[A Case of Late Onset Nivolumab-Induced Interstitial Nephritis in a Patient with Metastatic Renal Cell Carcinoma]Kodai Hattahara, Toshinari Yamasaki, Atsuro Sawada, et al.
Plos Pathogens|September 28, 2018
Infection with flaviviruses requires BCLXL for cell survivalTatsuya Suzuki, Toru Okamoto, Hiroshi Katoh, et al.
The Journal of Experimental Medicine|October 8, 2021
Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related virusesRyo Shinnakasu, Shuhei Sakakibara, Hiromi Yamamoto, et al.
Biochemical and Biophysical Research Communications|June 15, 2021
Identification of natural compounds extracted from crude drugs as novel inhibitors of hepatitis C virusXin Zheng, Rui Guo, Qingbo Liu, et al.
Journal of Virology|September 18, 2015
A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting PolypeptideManabu Kaneko, Koichi Watashi, Shinji Kamisuki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 13, 2026
Hemorrhagic Risk of Transrectal Ultrasound-Guided Prostate Biopsy Under Continued Antithrombotic TherapyNaoki Akagi, Akihiko Nagoshi, Masashi Kubota, et al.
Pageof 20

Showing results (171-180 of 192) with videos related to

Sort By:
Pageof 20
The Journal of Biological Chemistry|December 15, 2019
The machinery for endocytosis of epidermal growth factor receptor coordinates the transport of incoming hepatitis B virus to the endosomal networkMasashi Iwamoto, Wakana Saso, Kazane Nishioka, et al.
World Journal of Urology|June 2, 2026
Applying classification of intraoperative adverse events (ClassIntra) to robot-assisted radical prostatectomy to predict the risk of postoperative adverse eventsShinya Somiya, Ryoichi Saito, Toru Kanno, et al.
Nature Communications|May 5, 2016
TRC8-dependent degradation of hepatitis C virus immature core protein regulates viral propagation and pathogenesisSayaka Aizawa, Toru Okamoto, Yukari Sugiyama, et al.
Vaccine|September 5, 2022
Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathologyTakuya Hemmi, Akira Ainai, Takao Hashiguchi, et al.
Hinyokika Kiyo. Acta Urologica Japonica|June 28, 2019
[A Case of Late Onset Nivolumab-Induced Interstitial Nephritis in a Patient with Metastatic Renal Cell Carcinoma]Kodai Hattahara, Toshinari Yamasaki, Atsuro Sawada, et al.
Plos Pathogens|September 28, 2018
Infection with flaviviruses requires BCLXL for cell survivalTatsuya Suzuki, Toru Okamoto, Hiroshi Katoh, et al.
The Journal of Experimental Medicine|October 8, 2021
Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related virusesRyo Shinnakasu, Shuhei Sakakibara, Hiromi Yamamoto, et al.
Biochemical and Biophysical Research Communications|June 15, 2021
Identification of natural compounds extracted from crude drugs as novel inhibitors of hepatitis C virusXin Zheng, Rui Guo, Qingbo Liu, et al.
Journal of Virology|September 18, 2015
A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting PolypeptideManabu Kaneko, Koichi Watashi, Shinji Kamisuki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 13, 2026
Hemorrhagic Risk of Transrectal Ultrasound-Guided Prostate Biopsy Under Continued Antithrombotic TherapyNaoki Akagi, Akihiko Nagoshi, Masashi Kubota, et al.
Pageof 20